Perindopril Erbumine
Product Images NDC 10135-600

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Perindopril Erbumine (NDC 10135-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Perindopril Erbumine. (Perindopril Erbumine 01)

The text appears to be a chemical formula consisting of two molecules. The first molecule has a carbon atom double-bonded to an oxygen atom, followed by two carbon atoms, each attached to three hydrogen atoms and one methyl (CH3) group. The second molecule has a chain of carbon and nitrogen atoms, with variously attached methyl and ethyl groups. A meaningful description of the context and purpose of these molecules cannot be inferred from this text alone.*

FDA Label Image

Figure 1. (Perindopril Erbumine 02)

This is a figure depicting the time to the occurrence of the primary endpoint, with the proportion of participants who had cardiovascular mortality, non-fatal M or cardiac arrest over time (measured in years). The figure compares the results for Placebo and Perindopril, and shows a Logrank p value of 0.0003 for the Placebo group. The number of patients "at risk" is shown for each group at each interval.*

FDA Label Image

Figure 2. (Perindopril Erbumine 03)

This is a figure showing the beneficial effect of Perindopril treatment on the primary endpoint in predefined subgroups. The subgroups are divided into male and female categories and further categorized by age, previous myocardial infarction, hypertension, diabetes mellitus, lipid-lowering drugs, beta-blockers, and calcium-channel blockers. The size of the squares is proportional to the number of patients in each group, and a dashed line indicates the overall relative risk.*

FDA Label Image

Principal Display Panelndc 10135-0599-01perindoprilerbumine Tablets4 mgrx Only100 Tablets (Perindopril Erbumine 04)

Perindopril Erbumine Tablets 4mg Rx Only. Each tablet contains 4mg perindopril erbumine. It is recommended to keep out of reach of children. Dosage and administration details are provided in the accompanying literature. These tablets should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture. The product is manufactured by Patheon Pharmaceuticals Inc., Cincinnati, USA, and distributed by Marlex Pharmaceuticals Inc., New Castle, USA. The package has 100 tablets and the NDC number is 10135-0599-01.*

FDA Label Image

Principal Display Panelndc 10135-0600-01perindoprilerbumine Tablets8 mgrx Only100 Tablets (Perindopril Erbumine 05)

This text describes a medication with the NDC code 10135-0600-01. Each tablet contains 8mg of perindopril erbumine. The instructions for dosage and administration can be found in accompanying literature. The medication should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture. The medication is available in a bottle containing 100 tablets. This medication is manufactured by Patheon Pharmaceuticals, Inc in Cincinnati, Ohio, and distributed by Marlex Pharmaceuticals, Inc. It is made in the USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.